Animal Welfare Hub

Evidence-based resources for animal welfare

companion

Histiocytic Sarcoma in Dogs: Welfare and Palliative Care

Histiocytic sarcoma is an aggressive cancer in dogs, particularly affecting certain breeds. This guide covers welfare-centred management and palliative care.

Key Facts

Histiocytic sarcoma is highly aggressive with rapid progression
Bernese Mountain Dogs, Rottweilers, and Flat-coated Retrievers are predisposed
Localised forms can be treated surgically; disseminated forms have poor prognosis
Signs include lethargy, weight loss, respiratory distress, and lameness
CCNU (lomustine) chemotherapy may provide temporary disease control
Quality of life assessment is central to management decisions

Welfare Considerations and Management

Welfare-centred management of histiocytic sarcoma prioritises quality of life over aggressive treatment in most cases. For disseminated disease, palliative care with anti-inflammatories, appetite stimulants, and pain management supports comfort. Treatment decisions should be made collaboratively considering the dog's current quality of life, treatment burdens, and realistic prognosis.

What You Can Do

Seek specialist oncology assessment for treatment options and prognosis
Use validated quality of life scales to guide treatment decisions
Palliative care can maintain good welfare even without curative treatment
Consider hospice-style care focused on comfort and enjoyment of life